Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Lung Cancer
Lung Cancer
,
Oncology
Smoking Cessation and Lung Cancer
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Screening for Lung Cancer
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Who Should be Screened for Lung Cancer?
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Common Presenting Factors for NSCLC
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Shifts in Lung Cancer Treatment
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
A Look at PD-1 and PD-L1 Inhibitors
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
ALK Gene Rearrangement and PD-L1 Expression
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Differences in NSCLC Patient Populations
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Choosing the Right Therapy for Patients with NSCLC
Edward Garon, MD
Read More
Lung Cancer
,
Oncology
Immunotherapies and Lung Cancer
Edward Garon, MD
Read More
1
2
3
4
5
Page 3 of 5
Results 21 - 30 of 44